Summit Global Investments’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Sell |
181,653
-169,086
| -48% | -$2.61M | 0.17% | 90 |
|
|
2025
Q1 | $5.22M | Sell |
350,739
-378,461
| -52% | -$5.63M | 0.38% | 44 |
|
|
2024
Q4 | $9.66M | Buy |
729,200
+313,642
| +75% | +$4.15M | 0.6% | 37 |
|
|
2024
Q3 | $5.91M | Buy |
415,558
+192,143
| +86% | +$2.73M | 0.38% | 56 |
|
|
2024
Q2 | $2.89M | Sell |
223,415
-34,378
| -13% | -$445K | 0.2% | 105 |
|
|
2024
Q1 | $3.58M | Sell |
257,793
-80,622
| -24% | -$1.12M | 0.27% | 81 |
|
|
2023
Q4 | $4.83M | Buy |
338,415
+2,091
| +0.6% | +$29.8K | 0.32% | 70 |
|
|
2023
Q3 | $5.2M | Buy |
336,324
+246,886
| +276% | +$3.82M | 0.35% | 59 |
|
|
2023
Q2 | $1.41M | Buy |
+89,438
| New | +$1.41M | 0.09% | 169 |
|
|
2021
Q4 | – | Sell |
-127,237
| Closed | -$2.08M | – | 610 |
|
|
2021
Q3 | $2.08M | Buy |
127,237
+6,927
| +6% | +$113K | 0.16% | 122 |
|
|
2021
Q2 | $2.03M | Sell |
120,310
-9,115
| -7% | -$153K | 0.12% | 135 |
|
|
2021
Q1 | $2.36M | Sell |
129,425
-72,577
| -36% | -$1.33M | 0.15% | 110 |
|
|
2020
Q4 | $3.68M | Buy |
202,002
+81,680
| +68% | +$1.49M | 0.37% | 63 |
|
|
2020
Q3 | $2.15M | Buy |
120,322
+41,886
| +53% | +$747K | 0.22% | 69 |
|
|
2020
Q2 | $1.41M | Buy |
+78,436
| New | +$1.41M | 0.16% | 90 |
|